C7orf50 Antibody (D-11): sc-390201
- C7orf50 Antibody (D-11) is a mouse monoclonal IgG1 κ C7orf50 antibody provided at 200 µg/ml
- raised against a peptide mapping within an internal region of C7orf50 of human origin
- C7orf50 Antibody (D-11) is recommended for detection of C7orf50 of mouse, rat and human origin by WB, IP, IF and ELISA
- Anti-C7orf50 Antibody (D-11) is available conjugated to agarose for IP; HRP for WB, IHC(P) and ELISA; and to either phycoerythrin or FITC for IF, IHC(P) and FCM
- also available conjugated to Alexa Fluor® 488, Alexa Fluor® 546, Alexa Fluor® 594 or Alexa Fluor® 647 for WB (RGB), IF, IHC(P) and FCM, and for use with RGB fluorescent imaging systems, such as iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
- also available conjugated to Alexa Fluor® 680 or Alexa Fluor® 790 for WB (NIR), IF and FCM; for use with Near-Infrared (NIR) detection systems, such as LI-COR®Odyssey®, iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
- m-IgG Fc BP-HRP, m-IgG1 BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for C7orf50 Antibody (D-11) for WB applications. These reagents are now offered in bundles with C7orf50 Antibody (D-11) (see ordering information below).
QUICK LINKS
SEE ALSO...
C7orf50 Antibody (D-11) is a mouse monoclonal IgG1 kappa light chain antibody that detects C7orf50 of mouse, rat, and human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Anti-C7orf50 antibody (D-11) is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. C7orf50 is located on chromosome 7, which is significant as this chromosome is associated with various genetic disorders, including Osteogenesis imperfecta and Pendred syndrome. C7orf50, still provisionally designated, plays a role in cellular processes that are crucial for maintaining genomic stability and proper cellular function. Understanding C7orf50′s location and function is vital, as alterations in expression or function may contribute to the pathogenesis of diseases linked to chromosome 7. Deletion of specific regions of chromosome 7 has been implicated in conditions such as Williams-Beuren syndrome, characterized by cognitive challenges and distinctive physical features, as well as various myeloid disorders, including acute myelogenous leukemia. Using C7orf50 (D-11) antibody in research can provide insights into the biological significance of C7orf50 and potential implications in health and disease.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
C7orf50 Antibody (D-11) References:
- The DNA sequence of human chromosome 7. | Hillier, LW., et al. 2003. Nature. 424: 157-64. PMID: 12853948
- The neurobiology of Williams syndrome: cascading influences of visual system impairment? | Eckert, MA., et al. 2006. Cell Mol Life Sci. 63: 1867-75. PMID: 16810457
- Shwachman-Diamond syndrome. | Shimamura, A. 2006. Semin Hematol. 43: 178-88. PMID: 16822460
- Williams-Beuren syndrome diagnosis using fluorescence in situ hybridization. | Osborne, LR., et al. 2006. Methods Mol Med. 126: 113-28. PMID: 16930009
- Lissencephaly 1 linking to multiple diseases: mental retardation, neurodegeneration, schizophrenia, male sterility, and more. | Reiner, O., et al. 2006. Neuromolecular Med. 8: 547-65. PMID: 17028375
- Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies. | Brezinová, J., et al. 2007. Cancer Genet Cytogenet. 173: 10-6. PMID: 17284364
- Therapy-related leukemia and myelodysplasia: susceptibility and incidence. | Leone, G., et al. 2007. Haematologica. 92: 1389-98. PMID: 17768113
- Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta. | Tsipouras, P., et al. 1983. J Clin Invest. 72: 1262-7. PMID: 6313757
- Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. | Liang, H., et al. 1998. Proc Natl Acad Sci U S A. 95: 3781-5. PMID: 9520444
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
C7orf50 Antibody (D-11) | sc-390201 | 200 µg/ml | $316.00 | |||
C7orf50 Antibody (D-11): m-IgG Fc BP-HRP Bundle | sc-530093 | 200 µg Ab; 10 µg BP | $354.00 | |||
C7orf50 Antibody (D-11): m-IgGκ BP-HRP Bundle | sc-523447 | 200 µg Ab, 40 µg BP | $354.00 | |||
C7orf50 Antibody (D-11): m-IgG1 BP-HRP Bundle | sc-543866 | 200 µg Ab; 20 µg BP | $354.00 | |||
C7orf50 Antibody (D-11) AC | sc-390201 AC | 500 µg/ml, 25% agarose | $416.00 | |||
C7orf50 Antibody (D-11) HRP | sc-390201 HRP | 200 µg/ml | $316.00 | |||
C7orf50 Antibody (D-11) FITC | sc-390201 FITC | 200 µg/ml | $330.00 | |||
C7orf50 Antibody (D-11) PE | sc-390201 PE | 200 µg/ml | $343.00 | |||
C7orf50 Antibody (D-11) Alexa Fluor® 488 | sc-390201 AF488 | 200 µg/ml | $357.00 | |||
C7orf50 Antibody (D-11) Alexa Fluor® 546 | sc-390201 AF546 | 200 µg/ml | $357.00 | |||
C7orf50 Antibody (D-11) Alexa Fluor® 594 | sc-390201 AF594 | 200 µg/ml | $357.00 | |||
C7orf50 Antibody (D-11) Alexa Fluor® 647 | sc-390201 AF647 | 200 µg/ml | $357.00 | |||
C7orf50 Antibody (D-11) Alexa Fluor® 680 | sc-390201 AF680 | 200 µg/ml | $357.00 | |||
C7orf50 Antibody (D-11) Alexa Fluor® 790 | sc-390201 AF790 | 200 µg/ml | $357.00 | |||
C7orf50 (D-11) Neutralizing Peptide | sc-390201 P | 100 µg/0.5 ml | $68.00 |